These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7636324)

  • 61. Effects of oxygenation and pH on tumor cell response to alkylating chemotherapy.
    Siemann DW; Chapman M; Beikirch A
    Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):287-9. PubMed ID: 1991690
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The effect of radiosensitizers on the pharmacokinetics of melphalan and cyclophosphamide in the mouse.
    Hinchliffe M; McNally NJ; Stratford MR
    Br J Cancer; 1983 Sep; 48(3):375-83. PubMed ID: 6615699
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Chemopotentiation in vivo: no loss of sensitization with fractionation.
    Hill SA; Siemann DW
    Br J Cancer; 1984 Oct; 50(4):509-17. PubMed ID: 6487517
    [TBL] [Abstract][Full Text] [Related]  

  • 64. In vivo potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by the radiation sensitizer benznidazole.
    Siemann DW; Morrissey S; Wolf K
    Cancer Res; 1983 Mar; 43(3):1010-3. PubMed ID: 6825075
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The in vivo response of a C3H mammary carcinoma to treatment with misonidazole, cyclophosphamide and radiation.
    Grau C; Zachariae C; Mao HS; Overgaard J
    Acta Oncol; 1990; 29(6):769-74. PubMed ID: 2223148
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Misonidazole enhancement of the action of BCNU and melphalan against human melanoma xenografts.
    Clutterbuck RD; Millar JL; McElwain TJ
    Am J Clin Oncol; 1982 Feb; 5(1):73-8. PubMed ID: 7081141
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Potentiation of melphalan activity in the KHT sarcoma by the radiosensitizer RSU 1069.
    Siemann DW; Maddison K; Wolf K
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1657-60. PubMed ID: 6548212
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The effects of melphalan and misonidazole on the vasculature of a murine sarcoma.
    Murray JC; Randhawa V; Denekamp J
    Br J Cancer; 1987 Mar; 55(3):233-8. PubMed ID: 3552014
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of misonidazole and hyperthermia on the radiosensitivity of a C3H mouse mammary carcinoma and its surrounding normal tissue.
    Overgaard J
    Br J Cancer; 1980 Jan; 41(1):10-21. PubMed ID: 7362770
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Significance of additive heat effect in the therapeutic gain factor in combined hyperthermia and radiotherapy: murine tumor response and foot reaction.
    Sougawa M; Urano M
    Int J Radiat Oncol Biol Phys; 1991 Nov; 21(6):1561-8. PubMed ID: 1938566
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Combinations of CCNU, MISO, and fractionated radiotherapy.
    Siemann DW; Alliet KL
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1379-82. PubMed ID: 3759559
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The effect of preirradiated tumour bed on the response of a murine fibrosarcoma to elevated temperatures.
    Urano M; Tanaka N
    Int J Hyperthermia; 1989; 5(5):617-24. PubMed ID: 2768896
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Interactions between misonidazole and hyperthermia in EMT6 spheroids.
    Morgan JE; Bleehen NM
    Br J Cancer; 1981 Dec; 44(6):810-8. PubMed ID: 7326192
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Docetaxel and hyperthermia: factors that modify thermal enhancement.
    Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
    J Surg Oncol; 2004 Oct; 88(1):14-20. PubMed ID: 15384091
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Trimodality therapy (drug/hyperthermia/radiation) with BCNU or mitomycin C.
    Herman TS; Teicher BA; Holden SA
    Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):375-82. PubMed ID: 2105922
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nitroimidazoles as modifiers of nitrosourea pharmacokinetics.
    Lee FY; Workman P
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1627-30. PubMed ID: 6237080
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Enhancing effect of pre-treatment of cells with misonidazole in hypoxia on their response to melphalan in air.
    Smith E; Stratford IJ; Adams GE
    Br J Cancer; 1982 Jul; 46(1):117-26. PubMed ID: 7104191
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Addition of mitomycin C to cis-diamminedichloroplatinum(II)/hyperthermia/radiation therapy in the FSaIIC fibrosarcoma.
    Herman TS; Teicher BA; Holden SA
    Int J Hyperthermia; 1991; 7(6):893-903. PubMed ID: 1806643
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Chemosensitization in vitro: potentiation of melphalan toxicity by misonidazole, metronidazole and nitrofurazone.
    Smith E; Lumley CE; Stratford IJ; Adams GE
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):615-7. PubMed ID: 7107383
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Timing and sequence of hyperthermia in fractionated radiotherapy of a murine fibrosarcoma.
    Nishimura Y; Urano M
    Int J Radiat Oncol Biol Phys; 1993 Oct; 27(3):605-11. PubMed ID: 8226155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.